1. Acosta, F. J., Hernández, J. L., Pereira, J., Herrera, J., & Rodríguez, C. J. (2012). Medication adherence in schizophrenia. World Journal of Psychiatry, 2(5), 74–82. PubMed. https://doi.org/10.5498/wjp.v2.i5.74
2. Adebimpe, V. R. (1981). Overview: White norms and psychiatric diagnosis of black patients. American Journal of Psychiatry, 138(3), 279–285. https://doi.org/10.1176/ajp.138.3.279
3. Aklillu, E., Persson, I., Bertilsson, L., Johansson, I., Rodrigues, F., & Ingelman-Sundberg, M. (1996). Frequent distribution of ultrarapid metabolizers of debrisoquine in an Ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. Journal of Pharmacology and Experimental Therapeutics, 278(1), 441. http://jpet.aspetjournals.org/content/278/1/441.abstract
4. Allen, J. G., Rack, P., & Vaddadi, K. (1977). Differences in the effects of clomipramine on English and Asian volunteers: Preliminary report on a pilot study. Postgraduate Medical Journal, 53, 79–85.
5. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorder (5th ed.). American Psychiatric Publishing.